A Case of New-Onset Cardiomyopathy and Ventricular Tachycardia in a Patient Receiving Ibrutinib for Relapsed Mantle Cell Lymphoma

Clinical Case Reports- United Kingdom

doi 10.1002/ccr3.719

Full Text

Abstract

Available in

Categories

Date

October 17, 2016

Authors

Natalie Wallace

Publisher

Wiley

Related search

Palonosetron-Induced Ventricular Tachycardia in a Patient Receiving Cancer Chemotherapy

English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology

English

Polymorphic Ventricular Tachycardia in a Patient With Hypertrophic Cardiomyopathy and Digitalis Intoxication

Journal of Cardiology Cases

Cardiovascular Medicine

English

Ibrutinib Plus Palbociclib Has Efficacy in Mantle Cell Lymphoma

Cancer Discovery

English

Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma

British Journal of Haematology

English

Integrated Stress Response and Immune Cell Infiltration in an Ibrutinib-Refractory Mantle Cell Lymphoma Patient Following ONC201 Treatment

British Journal of Haematology

English

Mantle Cell Lymphoma: Conjunctival Mass in a Female Patient

Canadian Journal of Ophthalmology

English

Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Hematological Oncology

Cancer Research

English

Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor

International Journal of Basic & Clinical Pharmacology

English